logo
  

Vodafone, BTCL Announce New Partner Market Agreement For Botswana - Quick Facts

British telecom giant Vodafone Group Plc (VOD.L,VOD) Botswana Telecommunications Corporation Limited or BTCL jointly announced a new Partner Market agreement for Botswana, under which BTCL will become Vodafone's preferred partner in Botswana and the two companies will jointly offer business and consumer customers a range of products and services.

Under the agreement, BTCL will benefit from access to Vodafone best practice and will be able to enhance its customer proposition in Botswana with Vodafone's products and services.  Vodafone's multinational corporate customers will benefit from the addition of Botswana to their existing contracts for international managed services, while continuing to be serviced via a single point of contact.

As a preferred partner, BTCL will benefit from Vodafone's scale as the largest international voice carrier, with access to its global data reach and a competitive cost base for its customers' international calls.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT